BridGene strikes another partnership with Takeda as the latter company continues its dealmaking streak, following high-ticket agreements with Keros Therapeutics, AC Immune and Degron Therapeutics in ...
In honor of Rare Disease Day, the Celtics are teaming with Takeda Pharmaceuticals to raise awareness and support for the rare disease community.
Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback